BRIP1 and melanoma: Besides, FANCJ was found to be mutated in several other malignancies, including melanoma, breast, prostate, and hereditary colon cancer, suggesting that FANCJ mutations may be a risk factor in multiple tumor types (Cantor and Guillemette, 2011; Paulo et al, 2018; Ali et al, 2019).